BEAM
Price
$16.22
Change
+$0.23 (+1.44%)
Updated
May 7, 04:59 PM (EDT)
Capitalization
1.61B
97 days until earnings call
PROK
Price
$0.64
Change
-$0.05 (-7.25%)
Updated
May 7, 04:59 PM (EDT)
Capitalization
89.38M
2 days until earnings call
Ad is loading...

BEAM vs PROK

Header iconBEAM vs PROK Comparison
Open Charts BEAM vs PROKBanner chart's image
Beam Therapeutics
Price$16.22
Change+$0.23 (+1.44%)
Volume$33.95K
Capitalization1.61B
ProKidney
Price$0.64
Change-$0.05 (-7.25%)
Volume$13.6K
Capitalization89.38M
BEAM vs PROK Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PROK commentary
May 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and PROK is a Hold.

Ad is loading...
COMPARISON
Comparison
May 08, 2025
Stock price -- (BEAM: $15.99 vs. PROK: $0.69)
Brand notoriety: BEAM and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 197% vs. PROK: 71%
Market capitalization -- BEAM: $1.61B vs. PROK: $89.38M
BEAM [@Biotechnology] is valued at $1.61B. PROK’s [@Biotechnology] market capitalization is $89.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • PROK’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than PROK.

Price Growth

BEAM (@Biotechnology) experienced а -18.87% price change this week, while PROK (@Biotechnology) price change was -36.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.53%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was -14.13%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

PROK is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-4.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.61B) has a higher market cap than PROK($89.4M). BEAM YTD gains are higher at: -35.524 vs. PROK (-59.172). PROK has higher annual earnings (EBITDA): -131.07M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. PROK (407M). PROK has less debt than BEAM: PROK (6.44M) vs BEAM (161M). BEAM has higher revenues than PROK: BEAM (63.5M) vs PROK (0).
BEAMPROKBEAM / PROK
Capitalization1.61B89.4M1,799%
EBITDA-383.98M-131.07M293%
Gain YTD-35.524-59.17260%
P/E RatioN/AN/A-
Revenue63.5M0-
Total Cash851M407M209%
Total Debt161M6.44M2,500%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPROK
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 9 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWUAX78.29N/A
N/A
American Century Ultra® A
STFFX42.96N/A
N/A
Allspring Large Cap Growth R6
MGISX35.14N/A
N/A
Morgan Stanley Inst Global Franchise R6
SIFZX22.92N/A
N/A
Saturna International Z
PISJX15.00N/A
N/A
Columbia Pyrford International Stock R

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-8.40%
RXRX - PROK
48%
Loosely correlated
-12.62%
RNA - PROK
41%
Loosely correlated
-18.65%
ACLX - PROK
40%
Loosely correlated
-18.33%
GBIO - PROK
40%
Loosely correlated
-8.42%
BEAM - PROK
39%
Loosely correlated
-19.32%
More